Navigation Links
Regeneron Reports Fourth Quarter and Full Year 2012 Financial and Operating Results
Date:2/14/2013

utive Officer of Regeneron.  "With the recent U.S. approval of EYLEA for the treatment of macular edema following central retinal vein occlusion (CRVO), and receipt of a Medicare J-Code for EYLEA in January 2013, we expect continued strong U.S. growth for EYLEA and forecast U.S. net sales of $1.2 billion to $1.3 billion in 2013.  Outside the U.S., our partner Bayer HealthCare has begun to launch EYLEA for the treatment of neovascular age-related macular degeneration (wet AMD) in Japan, Europe, Australia, and other regions, and we expect to see substantial sales growth through 2013 and beyond as pricing approvals are received." 

"Clinical development of EYLEA in additional indications continued to progress in 2012, as the Phase 3 program in diabetic macular edema (DME) was fully enrolled and a Phase 3 trial in macular edema following branch retinal vein occlusion (BRVO) was initiated," said George D. Yancopoulos, M.D., Ph.D., Chief Scientific Officer, and President, Regeneron Laboratories.  "Our pipeline also advanced significantly during 2012, with the roll-out of our broad Phase 3 ODYSSEY program for REGN727, an antibody targeting PCSK9 to reduce low-density lipoprotein (LDL) cholesterol, and the full enrollment of our first Phase 3 trial for sarilumab, our IL-6 receptor antibody in rheumatoid arthritis.  We are also encouraged by the potential of our IL-4R inhibitor, REGN668.  REGN668 demonstrated positive proof of concept in allergic asthma and atopic dermatitis, and data from these trials will be submitted to medical conferences for presentation later in the year.  We look forward to starting later stage, Phase 2b trials with this antibody during 2013."

Business Highlights - Fourth Quarter 2012 and 2013 to Date EYLEA® (aflibercept) Injection for Intravitreal Injection

  • The Company and Bayer HealthCare collaborate on the global development and commercialization of EYLEA outside the U
    '/>"/>

  • SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Regeneron Announces Receipt of Hart-Scott-Rodino Notice
    2. Regeneron to Report Fourth Quarter and Full Year 2012 Financial and Operating Results and Host Conference Call and Webcast on February 14, 2013
    3. Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
    4. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
    5. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
    6. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
    7. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
    8. Regeneron Announces September 2012 Investor Conference Presentations
    9. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
    10. Regeneron Announces June 2012 Investor Conference Presentations
    11. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)... 2014  When it comes to welcoming our new robot ... roll out the red carpet. Healthcare is one ... 9000-like robots into our human sphere. With healthcare concerns top ... need to apply new technologies to help with old problems. ... robotics is expected to increase from $1.7 billion now to ...
    (Date:7/23/2014)... 23, 2014  Nearly 8,000 attendees will converge in ... annual Retail Business Conference (RBC), taking place July 23-26 ... year,s event encourages pharmacists to "Lead Change" in the ... for their future. "RBC is ... with their peers and learn new ways they can ...
    (Date:7/23/2014)... 23, 2014  Cardica, Inc. (Nasdaq: CRDC ) ... fiscal fourth quarter and year ended June 30, 2014, on ... will host a conference call at 4:30 p.m. Eastern Time ... the company,s business. Conference Call Details To access ... p.m. Eastern Time via phone, please dial 866-953-6859 from ...
    Breaking Medicine Technology:Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2
    ... , PALO ALTO, Calif., Dec. 2 ... 25, 2009, Varian, Inc. filed with the U.S. Securities and Exchange ... ended October 2, 2009. This Annual Report may be accessed ... and "SEC Filings," and then on "10-K" in the table shown. ...
    ... , ST. LOUIS, Dec. 2 KV Pharmaceutical Company ... an employment agreement with Interim President and Chief Executive Officer ... 2011. Mr. Van Vliet has served as Interim President and ... provides continuity of senior leadership as the Company seeks to ...
    Cached Medicine Technology:KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet 2
    (Date:7/23/2014)... 23, 2014 Ticket Down is ... tickets in Dallas, TX at the Cotton Bowl. The ... held in the United States and Canada beginning on July ... teams from La Liga, Serie A, English Premier League, and ... United, Manchester City, Olympiacos, Inter Milan, Liverpool, AS Roma, and ...
    (Date:7/23/2014)... Recently, Agebc.com has launched its new collection ... announcing a promotion of wedding dresses. According to a ... the end of this month. , The beautiful wedding ... A-line, mermaid, ball-gown, empire, and more. Agebc.com is a ... dresses for women, and the company is devoted to ...
    (Date:7/23/2014)... A Forever Recovery, an open-ended drug and ... great start and gives them a solid foundation in ... Internet Addiction section of its website at http://aforeverrecovery.com/behavioral-addictions/internet-addiction/ ... Internet addiction is not just as legitimate a disorder ... trapping more and more victims each year – particularly ...
    (Date:7/23/2014)... Karen Pallarito HealthDay Reporter ... day for Obamacare, two federal appeals courts arrived at completely ... to millions of Americans who bought health insurance through the ... matter is headed for a showdown before the U.S. Supreme ... Appeals Court for the District of Columbia Circuit said that ...
    (Date:7/23/2014)... -- For critically ill patients arriving at the ... analgesia, sedation and amnesia for rapid, life-saving intubation, ... pressure. The results of a systematic review ... physicians regard as a "wonder drug" are published ... " The Effect of Ketamine on Intracranial and ...
    Breaking Medicine News(10 mins):Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Slashes Ticket Prices on all AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 3Health News:Ketamine can be a wonder drug for ER patients and their physicians 2
    ... , , ... Democrat in Arcadia, LA recently reported that ... in treating cancers, introducing many new, breakthrough medicines . ... 861 new cancer medicines that are either in late-stage testing, ...
    ... , , MINNEAPOLIS , Jan. 29 ... it will continue to support efforts to save the General Assistance ... in payments for services, since the existing payments already do not ... to support broad-based tax increases that would support health care programs. ...
    ... , Statement by Jim Wordelman State Director for AARP Idaho ... of Congress figure out the next steps to take to tackle health ... by the day.  It,s time for Idaho ,s state and federal ... businesses, and retirees to deliver solutions as opposed to more roadblocks to ...
    ... , LOS ANGELES , Jan. 29 In a ... the nation,s organ donation and transplant community will vote for the best ... Seven Pounds , Return to Me , John Q ... Philadelphia Transplant Movie Night, a group of transplant recipients, living donors and ...
    ... Bill & Melinda Gates Foundation announced it would dedicate ... vaccine research, development and delivery throughout the developing world. ... pneumonia, diarrhea and malaria take the lives of 5 ... simply because life-saving vaccines don,t reach those who need ...
    ... Project A.L.S. (New York, NY) and the Robert Packard ... MD) announced that they will partner on, P2 ALS, ... Gehrig,s disease) research exponentially over the next three years. ... leaders in forging productive collaborations among research scientists, will ...
    Cached Medicine News:Health News:Cancer Medicines Pipeline Offers Patients Great Hope 2Health News:Doctors Tell Lawmakers to Find a New GAMC Fix 2Health News:Idaho's Health Care Woes Need Solutions, Not More Roadblocks 2Health News:Idaho's Health Care Woes Need Solutions, Not More Roadblocks 3Health News:Nationwide Vote to Determine Best Organ Donation-Themed Movie 2Health News:Project A.L.S. and Packard Center take aim at ALS with $15 million program 2
    Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
    10 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 2, 5 and 10 L pipettes....
    ... are ideal for PCR and ... any work where aerosol contamination ... for pipetting DNA/RNA solutions, infectious ... For applications requiring absolute sterility, ...
    Avant E-Z Rack Premium Low Binding 10 l Pipet Tips are accurate, contamination free, and allow quantitative transfer of your samples without relying on silicone....
    Medicine Products: